KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Recursion Pharmaceuticals (RXRX) Debt Ratio (2020 - 2025)

Historic Debt Ratio for Recursion Pharmaceuticals (RXRX) over the last 6 years, with Q3 2025 value amounting to 0.01.

  • Recursion Pharmaceuticals' Debt Ratio fell 6237.86% to 0.01 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.01, marking a year-over-year decrease of 6237.86%. This contributed to the annual value of 0.02 for FY2024, which is 98457.28% up from last year.
  • According to the latest figures from Q3 2025, Recursion Pharmaceuticals' Debt Ratio is 0.01, which was down 6237.86% from 0.02 recorded in Q2 2025.
  • In the past 5 years, Recursion Pharmaceuticals' Debt Ratio registered a high of 0.04 during Q2 2024, and its lowest value of 0.0 during Q4 2022.
  • Its 5-year average for Debt Ratio is 0.01, with a median of 0.0 in 2023.
  • Its Debt Ratio has fluctuated over the past 5 years, first plummeted by 9781.5% in 2022, then skyrocketed by 220858.4% in 2024.
  • Recursion Pharmaceuticals' Debt Ratio (Quarter) stood at 0.0 in 2021, then fell by 26.3% to 0.0 in 2022, then skyrocketed by 128.57% to 0.0 in 2023, then skyrocketed by 984.57% to 0.02 in 2024, then decreased by 21.48% to 0.01 in 2025.
  • Its last three reported values are 0.01 in Q3 2025, 0.02 for Q2 2025, and 0.02 during Q1 2025.